X

Trial Profile

Pharmacokinetic study of intranasal CT001 in children 1-17 years of age undergoing elective surgical procedures

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 22 Aug 2022

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Ketamine/sufentanil (Primary)
Indications Perioperative pain
Focus Pharmacokinetics
Sponsors Cessatech

Most Recent Events

17 Aug 2022 Status changed from active, no longer recruiting to completed.
16 May 2022 Status changed from recruiting to active, no longer recruiting, according to a Cessatech media release.
16 May 2022 According to a Cessatech media release, the last patient has been dosed in this trial. Topline results are anticipated by the end of Q3 2022

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com